These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 24672223)

  • 1. Diagnosis and management of neurotrophic keratitis.
    Sacchetti M; Lambiase A
    Clin Ophthalmol; 2014; 8():571-9. PubMed ID: 24672223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotrophic keratitis: current challenges and future prospects.
    Versura P; Giannaccare G; Pellegrini M; Sebastiani S; Campos EC
    Eye Brain; 2018; 10():37-45. PubMed ID: 29988739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular basis of neurotrophic keratopathy: Diagnostic and therapeutic implications. A review.
    Ruiz-Lozano RE; Hernandez-Camarena JC; Loya-Garcia D; Merayo-Lloves J; Rodriguez-Garcia A
    Ocul Surf; 2021 Jan; 19():224-240. PubMed ID: 33022412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limbal stem cell transplantation: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2008; 8(7):1-58. PubMed ID: 23074512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurotrophic keratopathy : Principles, diagnostics and treatment].
    Mergler S; Dietrich-Ntoukas T; Pleyer U
    Ophthalmologe; 2019 Aug; 116(8):797-810. PubMed ID: 31372724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expert consensus on the identification, diagnosis, and treatment of neurotrophic keratopathy.
    Dana R; Farid M; Gupta PK; Hamrah P; Karpecki P; McCabe CM; Nijm L; Pepose JS; Pflugfelder S; Rapuano CJ; Saini A; Gibbs SN; Broder MS
    BMC Ophthalmol; 2021 Sep; 21(1):327. PubMed ID: 34493256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current and experimental treatment approaches for neurotrophic keratopathy].
    Alder J; Mertsch S; Menzel-Severing J; Geerling G
    Ophthalmologe; 2019 Feb; 116(2):127-137. PubMed ID: 30707284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotrophic keratopathy: current challenges and future prospects.
    NaPier E; Camacho M; McDevitt TF; Sweeney AR
    Ann Med; 2022 Dec; 54(1):666-673. PubMed ID: 35243932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Treatment for Neurotrophic Corneal Ulcer Using Topical Cenegermin (OXERVATE™) Containing Recombinant Human Nerve Growth Factor.
    Ahuja AS; Bowden FW; Robben JL
    Cureus; 2020 Nov; 12(11):e11724. PubMed ID: 33391953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cenegermin for the treatment of neurotrophic keratitis.
    Sacchetti M; Bruscolini A; Lambiase A
    Drugs Today (Barc); 2017 Nov; 53(11):585-595. PubMed ID: 29451275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corneal changes in neurosurgically induced neurotrophic keratitis.
    Lambiase A; Sacchetti M; Mastropasqua A; Bonini S
    JAMA Ophthalmol; 2013 Dec; 131(12):1547-53. PubMed ID: 24158681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotrophic keratopathy: An updated understanding.
    Neurotrophic Keratopathy Study Group
    Ocul Surf; 2023 Oct; 30():129-138. PubMed ID: 37666470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotrophic factors and corneal nerve regeneration.
    Sacchetti M; Lambiase A
    Neural Regen Res; 2017 Aug; 12(8):1220-1224. PubMed ID: 28966630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amniotic membrane transplantation for managing dry eye and neurotrophic keratitis.
    Mead OG; Tighe S; Tseng SCG
    Taiwan J Ophthalmol; 2020; 10(1):13-21. PubMed ID: 32309119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical picture and diagnosis of neurotrophic keratopathy].
    Messmer EM
    Ophthalmologe; 2019 Feb; 116(2):120-126. PubMed ID: 30535856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the Pathogenesis of Neurotrophic Keratitis: The Role of Corneal Nerves.
    Mastropasqua L; Massaro-Giordano G; Nubile M; Sacchetti M
    J Cell Physiol; 2017 Apr; 232(4):717-724. PubMed ID: 27683068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of response to multimodal management of neurotrophic corneal disease.
    Trinh T; Santaella G; Mimouni M; Mednick Z; Cohen E; Sorkin N; Rootman DS; Slomovic AR; Chan CC
    Ocul Surf; 2021 Jan; 19():330-335. PubMed ID: 33189904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Pharmacological Approaches for the Treatment of Neurotrophic Keratitis.
    Koay SY; Larkin DFP
    Front Pharmacol; 2022; 13():796854. PubMed ID: 35392574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the Medical Management of Neurotrophic Keratitis.
    Dohlman TH; Singh RB; Dana R
    Semin Ophthalmol; 2021 May; 36(4):335-340. PubMed ID: 33705259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and instrumental assessment of the corneal healing in moderate and severe neurotrophic keratopathy treated with rh-NGF (Cenegermin).
    Roszkowska AM; Inferrera L; Aragona E; Gargano R; Postorino EI; Aragona P
    Eur J Ophthalmol; 2022 Nov; 32(6):3402-3410. PubMed ID: 35473440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.